Cargando…

224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study

BACKGROUND: Bloodstream infections (BSI) are a major cause of morbidity, mortality, and health care costs worldwide. Population-based studies are key to assess BSI epidemiology over time while minimizing selection bias but remain limited. Therefore, we aimed to assess the incidence of BSI in a large...

Descripción completa

Detalles Bibliográficos
Autores principales: Niazi, Elaha, Mponponsuo, Kwadwo, Somayaji, Ranjani, Rennert-May, Elissa, Conly, John, Gregson, Dan, Leal, Jenine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643749/
http://dx.doi.org/10.1093/ofid/ofab466.426
_version_ 1784609924378001408
author Niazi, Elaha
Mponponsuo, Kwadwo
Somayaji, Ranjani
Rennert-May, Elissa
Conly, John
Gregson, Dan
Leal, Jenine
author_facet Niazi, Elaha
Mponponsuo, Kwadwo
Somayaji, Ranjani
Rennert-May, Elissa
Conly, John
Gregson, Dan
Leal, Jenine
author_sort Niazi, Elaha
collection PubMed
description BACKGROUND: Bloodstream infections (BSI) are a major cause of morbidity, mortality, and health care costs worldwide. Population-based studies are key to assess BSI epidemiology over time while minimizing selection bias but remain limited. Therefore, we aimed to assess the incidence of BSI in a large Canadian health region in a contemporary period. We hypothesized that there would be significant age and sex-based differences including over time. METHODS: We conducted a retrospective cohort study from 2011 through 2018 using a population-based microbiology database to determine the annual age- and sex-specific BSI testing and case rates with the census as the population reference. BSI was defined as a positive blood culture for a pathogen. Episodes > 30 days apart were included for analysis. Incidence rate ratios (IRR) for testing and case rates including by sex were calculated to assess changes over time. All analyses were run at a two-sided α of 0.05 and were conducted with R 4.0.4. RESULTS: A total of 154,147 distinct individuals (49.9% male) were analyzed and 22,869 (14.8%) had a BSI at the first encounter in the study period. Overall BSI testing incidence ranged from 1529 to 1707 per 100,000 person-years and case incidence ranged from 180 to 292 per 100,000 person-years. Testing and case incidence for BSI was greatest in the 0-4 and 75+ years age groups (p < 0.01). Males compared to females had greater testing and case incidence rates in young and old age groups, but females had greater rates in the 15-44 years groups (p < 0.01). Overall IRR for cases comparing 2018 to 2011 was 0.62 (95% CI 0.59-0.65) reflecting a significant decrease over time. Testing also decreased over the study period with an IRR of 0.90 (95% CI 0.88-0.91). Testing and case IRRs were not significantly different stratified by sex. Incidence rates (per 100,000 person-years) of BSI testing and cases by sex from 2011 through 2018 in a Canadian health region [Image: see text] CONCLUSION: In our large population-based study of BSI, we identified that BSI remain frequent and the youngest and oldest age groups as well as males in these age groups have the greatest BSI incidence rates which may reflect both biological sex and gender-based differences. Encouragingly, BSI incidence rates have decreased over time at a greater increment relative to testing rates. Future studies of BSI should focus on pathogen and outcome-based evaluations. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8643749
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86437492021-12-06 224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study Niazi, Elaha Mponponsuo, Kwadwo Somayaji, Ranjani Rennert-May, Elissa Conly, John Gregson, Dan Leal, Jenine Open Forum Infect Dis Poster Abstracts BACKGROUND: Bloodstream infections (BSI) are a major cause of morbidity, mortality, and health care costs worldwide. Population-based studies are key to assess BSI epidemiology over time while minimizing selection bias but remain limited. Therefore, we aimed to assess the incidence of BSI in a large Canadian health region in a contemporary period. We hypothesized that there would be significant age and sex-based differences including over time. METHODS: We conducted a retrospective cohort study from 2011 through 2018 using a population-based microbiology database to determine the annual age- and sex-specific BSI testing and case rates with the census as the population reference. BSI was defined as a positive blood culture for a pathogen. Episodes > 30 days apart were included for analysis. Incidence rate ratios (IRR) for testing and case rates including by sex were calculated to assess changes over time. All analyses were run at a two-sided α of 0.05 and were conducted with R 4.0.4. RESULTS: A total of 154,147 distinct individuals (49.9% male) were analyzed and 22,869 (14.8%) had a BSI at the first encounter in the study period. Overall BSI testing incidence ranged from 1529 to 1707 per 100,000 person-years and case incidence ranged from 180 to 292 per 100,000 person-years. Testing and case incidence for BSI was greatest in the 0-4 and 75+ years age groups (p < 0.01). Males compared to females had greater testing and case incidence rates in young and old age groups, but females had greater rates in the 15-44 years groups (p < 0.01). Overall IRR for cases comparing 2018 to 2011 was 0.62 (95% CI 0.59-0.65) reflecting a significant decrease over time. Testing also decreased over the study period with an IRR of 0.90 (95% CI 0.88-0.91). Testing and case IRRs were not significantly different stratified by sex. Incidence rates (per 100,000 person-years) of BSI testing and cases by sex from 2011 through 2018 in a Canadian health region [Image: see text] CONCLUSION: In our large population-based study of BSI, we identified that BSI remain frequent and the youngest and oldest age groups as well as males in these age groups have the greatest BSI incidence rates which may reflect both biological sex and gender-based differences. Encouragingly, BSI incidence rates have decreased over time at a greater increment relative to testing rates. Future studies of BSI should focus on pathogen and outcome-based evaluations. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8643749/ http://dx.doi.org/10.1093/ofid/ofab466.426 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Niazi, Elaha
Mponponsuo, Kwadwo
Somayaji, Ranjani
Rennert-May, Elissa
Conly, John
Gregson, Dan
Leal, Jenine
224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study
title 224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study
title_full 224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study
title_fullStr 224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study
title_full_unstemmed 224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study
title_short 224. Evaluating the Epidemiology of Bloodstream Infections: A Population-Based Study
title_sort 224. evaluating the epidemiology of bloodstream infections: a population-based study
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643749/
http://dx.doi.org/10.1093/ofid/ofab466.426
work_keys_str_mv AT niazielaha 224evaluatingtheepidemiologyofbloodstreaminfectionsapopulationbasedstudy
AT mponponsuokwadwo 224evaluatingtheepidemiologyofbloodstreaminfectionsapopulationbasedstudy
AT somayajiranjani 224evaluatingtheepidemiologyofbloodstreaminfectionsapopulationbasedstudy
AT rennertmayelissa 224evaluatingtheepidemiologyofbloodstreaminfectionsapopulationbasedstudy
AT conlyjohn 224evaluatingtheepidemiologyofbloodstreaminfectionsapopulationbasedstudy
AT gregsondan 224evaluatingtheepidemiologyofbloodstreaminfectionsapopulationbasedstudy
AT lealjenine 224evaluatingtheepidemiologyofbloodstreaminfectionsapopulationbasedstudy